Moscow, 8 July 2013 – Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (“Pharmstandard” or the “Company”) would like to inform that the Company is in advanced discussions on and shortly expects to sign definitive documentation in relation to a potential acquisition (the “Transaction”).
It is anticipated that the Transaction will be subject to approval of the Company’s shareholders.
Accordingly, Pharmstandard would like to announce the extraordinary shareholder meeting to approve the Transaction.
Further details of the Transaction would be announced upon signing definitive documentation.
Tel.: +7 (495) 970-0030 Ext.2824